The neuron is the target of inflammatory demyelinating processes in multiple sclerosis (MS).
Introduction
Progressive multiple sclerosis (MS) is a chronic inflammatory demyelinating disorder with ongoing neurodegeneration. (Stadelmann 2011) Inflammation is a potent inducer of damage to neurons, particularly axons and synapses in MS. Furthermore, the restoration of myelin to denuded axons (remyelination) is limited in progressive MS, which leaves the naked axons much more vulnerable to additional insults. There is an overall tendency for inflammation to become less prominent with increasing disease duration, although with case-to-case variability even at the end stage of the disease. (Mahad et al. 2015) In contrast to inflammation, the lesion burden or the extent of demyelination gradually increases partly due to lack of remyelination as well as ongoing and repeated inflammatory demyelination. The cumulative impact of inflammation and chronic demyelination leads to the loss of CNS tissue, as reflected by brain and spinal cord atrophy. Neuropathological studies indicate extensive loss of axons particularly in the spinal cord long tracts and synapses in the grey matter (>60-70% loss). (Bjartmar et al. 2003; Jurgens et al. 2016) In contrast, the extent of neuronal cell body loss in the cortical grey matter is marginal, with 15-20% loss, except in cases with so called follicle-like B cell infiltrated in the meninges. (Magliozzi et al. 2010) The existence of neuronal cell bodies at the end stage of progressive MS in autopsy tissue offers the opportunity to study their content and gain insight into how the neurons may play a role in and contribute to the neurodegenerative process of progressive MS.
We discuss the molecular, proteomic, biochemical and dynamic mitochondrial changes that are intrinsic to neurons, (Mahad et al. 2015) and how these molecular changes lead to an energy failure state through an increase in demand for ATP and a decrease in capacity to produce ATP by mitochondria.
Molecular changes within the neuronal cell bodies in progressive MS
It is abundantly clear that the mitochondria within neuronal cell bodies are damaged in progressive MS (Figure 1 ). All these molecular changes, discussed in more detail below, converge on mitochondrial function and transport. The molecular changes within neurons in progressive MS impact the mitochondrial respiratory chain complexes and hence the ability to produce ATP by oxidative phosphorylation.
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Mitochondrial respiratory chain complexes in neuronal cell bodies
The first detailed study of upper motor neurons from non-demyelinated motor cortex was reported by Dutta et al just over a decade ago. (Dutta et al. 2006 ) These authors subjected well-preserved grey matter tissue from rapid autopsy cases to microarrays in an unbiased manner and found the majority of the most significant molecular changes to be related to the mitochondrial respiratory chain complex subunits. They investigated nuclear DNA encoded transcripts and found 26 transcripts of mitochondrial respiratory chain complexes to have decreased significantly. This decrease in nuclear DNA encoded mitochondrial transcripts was neuron-specific and affected the majority of upper motor neurons. Furthermore, the transcript changes led to mitochondrial respiratory chain complex I and complex III deficiency. Notably, the mitochondrial respiratory chain deficient neurons were found in nondemyelinated motor cortex, which suggests a role for pathological processes such as demyelination of the axon in the white matter in the generation of neuronal mitochondrial defects in MS.
Since the publication of the above study in 2006, the decrease in nuclear DNA encoded mitochondrial respiratory chain transcripts in non-demyelinated cortex has been observed by others. (Broadwater et al. 2011; Witte et al. 2013 ) An independent group identified the transcripts of mitochondrial respiratory chain complexes to have significantly decreased in both the cingulate gyrus and frontal cortex. (Witte et al. 2013 ) Furthermore, authors of this study identified a significant decrease (quarter to one third) in mRNA level of peroxisome proliferator-activated receptor (PPAR)-gamma coactivator 1-alpha (PGC-1alpha), a master regulator of metabolism and mitochondrial function. The decrease in PGC-1alpha was evident in the deeper cortical layers (layers IV-VI). The mitochondrial respiratory chain complex deficiency in non-demyelinated motor cortex was associated with a decrease in components of GABAergic neurotransmission and loss of inhibitory interneuron processes as well as a decrease in mitochondrial anti-oxidants. (Dutta et al. 2006; Witte et al. 2013) Broadwater and colleagues undertook a different experimental approach to investigate mitochondria in the non-demyelinated cortex in progressive MS cases. (Broadwater et al. 2011 ) Using mass spectroscopy they identified proteomic changes relating to the mitochondrial respiratory chain complexes in the normal appearing motor cortex in progressive MS. A significant decrease in mitochondrial respiratory chain complex IV subunit V was confirmed by western blots. Furthermore, another study indicated a number of nuclear DNA encoded and mitochondrial DNA encoded transcripts to have decreased in acute white matter MS lesions. (Fischer et al. 2012) 
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The cause(s) of these molecular changes intrinsic to neurons in progressive MS is not known, whether this is a primary effect or a secondary phenomenon following the loss of functional connectivity due to the loss of synapses and transection of the long projecting axon. In terms of the mitochondrial DNA deletions, the molecular events encompass a likely active or a positive selection phenomenon and the resulting mitochondrial respiratory chain complex deficiency is irreversible. Further studies are needed to understand both the cause of the neuronal molecular changes and the consequences of the neuronal mitochondrial respiratory chain deficiency,
Mitochondrial transport machinery within neurons in progressive MS
Beside the studies that found mitochondrial respiratory chain complex deficiency, other independent groups have identified changes that impact on the transport,of mitochondria from the cell body to the axon.
A study that investigated histone deacetylase 1 (HDAC1), which is an enzyme that is found within the nucleus and represses nuclear DNA transcription, detected aberrantly located enzyme in the cytoplasm and degenerated axons in MS autopsy tissue as well as in an in vivo experimental system with cuprizone induced demyelination. (Kim et al. 2010 ) This nuclear export of HDAC1 was neuron specific, related to the increase in calcium entry into the neuron and occurred prior to the damage to neuritis. The cytoplasmic HDAC1 formed protein complexes with kinesins (KIF2A and KIF5), which are motor proteins involved in anterograde transport of protein complexes, mRNA and membranous organelles, such as mitochondria, in axons. This interaction between cytoplasmic HDAC1 and kinesins, following exposure of neurons to glutamate and TNFalpha, impaired the anterograde transport of mitochondria in the axon. The inhibition of the nuclear export of HDAC1 using pharmacological agents prevented the damage to neurites. The impaired mitochondrial transport within axons in the context of inflammation was confirmed in experimental autoimmune encephalomyelitis (EAE) by another group. (Sorbara et al. 2014 ) Both anterograde and retrograde transport of mitochondria within axons was significantly decreased by a slower speed and more frequent stops. The transport deficits in EAE were rescued by methylprednisolone and redox scavengers. Further evidence of impaired anterograde transport of mitochondria in progressive MS is indicated by the significant decrease in motor proteins, called kinesins (KIF5A, KIF21B and KIF1B), within neurons. (Hares et al. 2013) 
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The impaired anterograde transport of mitochondria in neurons compromises the ability of the neuronal cell body to replenish the axon with new mitochondria. Whether agents, such as glucocorticoids, redox scavengers and anti-inflammatory drugs, that improve mitochondrial transport protect axons in progressive MS needs to be assessed in future studies. Furthermore, whether the manipulation of mitochondria protects demyelinated axons requires further investigation in pre-clinical systems that model the neuronal mitochondrial changes that are described in progressive MS.
Mitochondrial changes within demyelinated axons in MS
The energy demands and the distribution of mitochondria in the myelinated axon A number of studies carried out over the past decade has shown evidence of mitochondrial changes within the demyelinated axon. To understand the significance of these changes, it is important to recognise the role mitochondria have to play in the myelinated axon within the CNS. Directed by the requirement for energy, the precise location of mitochondria within the axoplasm is crucial to axonal function.
The major advantage of myelination of axons is the saltatory conduction of action potentials which results in their fast propagation along the nerve. Recent evidence also suggests that myelinating cells of the CNS, the oligodendrocytes, supply axonal mitochondria with the metabolites required for them to efficiently perform oxidative phosphorylation to produce ATP, the cellular energy currency. (Funfschilling et al. 2012 The variable distribution of the mitochondria is therefore likely to result from the changeable energy demands along the axon. It has also been hypothesized that axonal Ca 2+ is
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Many of these factors become increasingly important, as dramatic axonal metabolic changes in the event of demyelination lead to important modifications in mitochondrial dynamics.
The changing energy demands of the demyelinated axon
Unmyelinated axons (axons that are never myelinated) provide a useful guide as to the prediction of mitochondrial changes one might observe in the demyelinated axon. (Bristow et al. 2002) Studies of the unmyelinated axons of the lamina cribrosa (site where axons exit the eye posteriorly to join the optic nerve) have provided such information where complex IV activity has been investigated. Complex IV is the terminal subunit in the electron transport chain and consumes 90% of cellular oxygen. The unmyelinated segment of the lamina cribrosa was found to have increased complex IV activity compared to its myelinated counterpart, an indicator of increased energy demand, highlighted by the uniform distribution of certain isoforms of Na channels (Na v 1.1 and Na v 1.6) along the unmyelinated segment. (Bristow et al. 2002; Balaratnasingam et al. 2009 ) This is in contrast to myelinated axons where Na channels are specifically localized to the nodes of Ranvier within the CNS.
The early redistribution of Na channels along the denuded axonal segment has been shown to be a consistent feature of demyelinated axons, which may allow the continuation of action 
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Axon degeneration in progressive MS -a specific role for complex IV activity?
Axon degeneration is a significant pathological hallmark of MS, its importance highlighted by the hypothesis that axon loss is the crucial factor in the development of progressive MS from relapsing-remitting disease. (Bjartmar et al. 2003) Inflammation is a key cause of axon degeneration particularly during the initial stages of disease. Anti-inflammatory treatments, effective during the acute stage of disease are rendered redundant in the progressive stage of disease, the reasons for which remain unresolved. Chronic demyelinated lesions persist for decades and slow burning axonal degeneration persists in such chronic MS lesions. One hypothesis for inflammation-independent axon degeneration is that the neuronal mitochondrial dysfunction leads to a lack of ATP in the axon and the loss of Na + /K + ATPase activity, which is essential to maintain ionic balance in demyelinated axons (Waxman 2006 ). show an increase of axonal mitochondrial content upon demyelination, this is not always the case for complex IV activity. Following lysolecithin induced demyelination both mitochondrial content and complex IV activity increase within demyelinated axons. In contrast, we did not find a corresponding increase in complex IV activity within demyelinated axons in a number of EAE in mouse, rat and marmoset species, despite an increase in axonal mitochondrial content. Interestingly, the level of axonal of complex IV activity was significantly correlated with the amount of axonal damage within the demyelinated lesion, which was not the case for the amount of axonal mitochondrial content. Future studies should focus on the timing of complex IV loss and its relation to changes in axonal calcium level, mitochondrial reactive oxygen species production as well as mitochondrial membrane potential. Evidence from EAE suggests that the loss of axonal complex IV activity occurs relatively early compared with structural changes. The loss of complex IV activity in axonal mitochondria in EAE may precede axonal mitochondrial morphological changes. (Nikic et al. 2011) The mechanism of
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complex IV activity loss may be nitration of complex IV subunit IV that occurs in EAE prior even to the arrival of inflammatory cells. (Qi et al. 2006) The increased energy demand of demyelinated axons, highlighted by changes in the mitochondrial network, must be met by the neuronal cell body, the site of mitochondria generation (Figure 2 ). The dysfunction of the mitochondria in neuronal soma would therefore put the demyelinated axon at risk of degeneration.
Are the molecular changes intrinsic to neurons in progressive MS primary or secondary?
The nature of the autopsy tissue available in progressive MS makes the delineation of the time course of the neuron-specific irreversible mitochondrial injury challenging. Although biopsy material from early stage of MS has been used to define inflammation in the cortex such material is limited for more detailed analysis of mitochondria within neuronal cell bodies. (Lucchinetti et al. 2011) Inflammation is a potent inducer of reactive oxygen species and mitochondrial dysfunction in the CNS. Suppressing inflammation is an obvious strategy to limit or prevent mitochondrial dysfunction and facilitate the generation of healthy mitochondria in the surviving neurons. In progressive MS, however, our current view is that at least part of the molecular changes within neuronal cell bodies that compromise the mitochondrial respiratory chain are induced and irreversibly amplified within the CNS by the chronic inflammation and demyelination. Iron accumulation and increase in oxidative injury are likely to further amplify the mitochondrial damage over time. Chronic demyelination, as mentioned above, will be another factor that will trigger axonal mitochondrial injury independent of inflammation, as shown in Shiverer mice. (Joshi et al. 2015) Given the protracted clinical course of relapsing MS, the compromise of the neuronal compartment due to mitochondrial dysfunction may occur relatively early in progressive MS.
Therapeutic implication of the neuronal mitochondrial respiratory chain complex deficiency.
Immunomodulation has been a very successful strategy in relapsing MS and increasingly at least in a subset of patients with progressive MS. Drugs and monoclonal antibodies that target remyelination are currently being tested in clinical trials and appear to be a promising
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